ChemicalBook > CAS DataBase List > Saroglitazar

Saroglitazar

Product Name
Saroglitazar
CAS No.
495399-09-2
Chemical Name
Saroglitazar
Synonyms
Saroglitazar;(S)-2-Ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoic acid;Benzenepropanoic acid, α-ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]-, (αS)-
CBNumber
CB62708940
Molecular Formula
C25H29NO4S
Formula Weight
439.57
MOL File
495399-09-2.mol
More
Less

Saroglitazar Property

Boiling point:
621.0±55.0 °C(Predicted)
Density 
1.15±0.1 g/cm3(Predicted)
storage temp. 
Refrigerator
solubility 
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form 
Gel
pka
3.60±0.10(Predicted)
color 
Red
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H317May cause an allergic skin reaction

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
27851
Product name
Saroglitazar
Packaging
2.5mg
Price
$396
Updated
2024/03/01
TRC
Product number
S141650
Product name
Saroglitazar
Packaging
25mg
Price
$1390
Updated
2021/12/16
ChemScene
Product number
CS-6149
Product name
Saroglitazar
Purity
98.03%
Packaging
50mg
Price
$1920
Updated
2021/12/16
ChemScene
Product number
CS-6149
Product name
Saroglitazar
Purity
98.03%
Packaging
100mg
Price
$2760
Updated
2021/12/16
ChemScene
Product number
CS-6149
Product name
Saroglitazar
Purity
98.03%
Packaging
5mg
Price
$396
Updated
2021/12/16
More
Less

Saroglitazar Chemical Properties,Usage,Production

Description

Saroglitazar (also known as ZYH1) was approved for use by the Drug Controller General of India for the treatment of diabetic dyslipidemia and hypertriglyceridemia that is not controlled by statin therapy. Saroglitazar is the first approved agent with dual PPAR agonist activity, with EC50s of 0.00065 and 3 nM, respectively, for the α- and γ-PPAR isoforms in HepG2 cells. The medicinal chemistry program has not been described in the scientific literature, but numerous substituents on the pyrrole ring are described in the saroglitazar patent. These substituted pyrroles were synthesized via ethanolamine condensation with substituted diketones and subsequent activation of the hydroxyethylpyrrole for phenolic etherification with (S)-2- ethoxy-3-(4-hydroxyphenyl)propanoic acid. The efficacy of saroglitazar was evaluated in db/db mice (genetically diabetic animals that lack the leptin receptor), wherein it produced a 17–55% reduction in serum triglycerides (TGs) after 12 days of administration of saroglitazar (0.01–3 mg/kg).

Description

Saroglitazar is a dual agonist of PPARα and PPARγ (EC50s = 0.65 and 3,000 pM, respectively, in a transactivation assay in HepG2 cells). It decreases serum triglyceride, free fatty acid, and glucose levels in a db/db mouse model of diabetes when administered at doses ranging from 0.01 to 3 mg/kg per day for 12 days. It increases insulin sensitivity in an oral glucose challenge when administered at a dose of 1 mg/kg in db/db mice, as well as decreases LDL levels in hApoB100/hCETP mice and in hamsters fed a high-fat high-cholesterol diet. Saroglitazar (10 μM) reverses palmitic acid-induced decreases in the expression of superoxide dismutase 1 (SOD1), SOD2, glutathione peroxidase (GPX), and catalase and increases in TNF-α, IL-1β, and IL-6 expression in HepG2 cells. It decreases hepatic inflammation and steatosis in a mouse model of non-alcoholic steatohepatitis (NASH) induced by a choline-deficient high-fat diet when administered at a dose of 3 mg/kg and inhibits fibrosis in a mouse model of fibrosis induced by carbon tetrachloride.

Originator

Cadila Healthcare Ltd. (India)

Uses

Saroglitazar, is a drug for the treatment of diabetic dyslipidemia and hypertriglyceridemia with Type 2 diabetes mellitus not controlled by statin therapy. Its trade name is Lipaglyn. It is also a 1,2-Diarylpyrroles derivative, which can be used in the preparation of Nonsteroidal anti-inflammatory drugs (NSAIDs).

Definition

ChEBI: Saroglitazar is a monocarboxylic acid that is (2S)-2-ethoxy-3-(p-ethoxyphenyl)propanoic acid in which one of the methyl hydrogens of the p-ethoxy substituent has been replaced by the nitrogen of 2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrole. An agonist at the subtypes alpha and gamma of the peroxisome proliferator-activated receptor (PPAR) with predominant PPARalpha activity, it is used in the treatment of type 2 diabetes. It has a role as a PPARgamma agonist, a hypoglycemic agent and a PPARalpha agonist. It is a member of pyrroles, a monocarboxylic acid, a methyl sulfide and an aromatic ether.

brand name

Lipaglyn

Synthesis

The sequence began with a Paal¨CKnorr pyrrole synthesis starting from commercial 1-[4-(methylthio)phenyl]pentane-1,4-dione (148). Subjection of this diketone to ethanolamine in warm pivalic acid furnished pyrrole 149, which was taken forward as the crude product. Next, the alcohol was mesylated to afford 150, which was used without further purification. Williamson ether conditions were employed to convert mesylate 150 to the corresponding aryl ether 152 through the use of commercial phenol 151 and anhydrous potassium carbonate. This reaction proceeded in 80% yield. Saponification of the terminal ethyl ester using sodium hydroxide followed by acidic pH adjustment ultimately delivered the carboxylic acid drug saroglitazar (XX) in 98% yield from 152.

Saroglitazar Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Saroglitazar Suppliers

Beijing Jingzi Pharmaceutical Technology Co., Ltd.
Tel
15011485209
Email
17241816@qq.com
Country
China
ProdList
81
Advantage
58
Changzhou Bojia Biomedical Technology Co., Ltd.
Tel
2122619822
Email
czbjpharma@126.com
Country
China
ProdList
18488
Advantage
58
Nantong Hi-Future Biotechnology Co., Ltd
Tel
18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
3063
Advantage
58
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
94838
Advantage
76
Dtchem Laboratories,(Gan Su)Co.,Ltd.
Tel
18993966060
Fax
0943-8288977
Email
sales@techbiochem.com
Country
China
ProdList
937
Advantage
61
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4863
Advantage
58
Artis Biotech Co. Ltd.
Tel
19138486554 18582380095
Fax
0575-89298961
Email
sales@artisbio.com
Country
China
ProdList
2964
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131981
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4662
Advantage
60
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 13028896684
Email
sales@rrkchem.com
Country
China
ProdList
55896
Advantage
58
More
Less

View Lastest Price from Saroglitazar manufacturers

shandong perfect biotechnology co.ltd
Product
Saroglitazar 495399-09-2
Price
US $0.00/g
Min. Order
1g
Purity
98% HPLC
Supply Ability
100kgs
Release date
2023-08-14

495399-09-2, SaroglitazarRelated Search:


  • Saroglitazar
  • Benzenepropanoic acid, α-ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]-, (αS)-
  • (S)-2-Ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoic acid
  • 495399-09-2